Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for lynch syndrome

Journal of Clinical Oncology

Volumn 27, Issue 24, 2009, Pages 3981-3986

  Grover, Shilpa ^a   Stoffel, Elena M ^a   Mercado, Rowena C ^a   Ford, Beth M ^a   Kohlman, Wendy K ^a   Shannon, Kristen M ^a   Conrad, Peggy G ^a   Blanco, Amie M ^a   Terdiman, Jonathan P ^a   Gruber, Stephen B ^a   Chung, Daniel C ^a   Syngal, Sapna ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; MISMATCH REPAIR; MMR GENE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; ADOLESCENT; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; GENETIC COUNSELING; GENETICS; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CROSS-SECTIONAL STUDIES; DNA MISMATCH REPAIR; FEMALE; GENETIC COUNSELING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 69849099009     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.6940     Document Type: Article

References (26)

1. Aaltonen LA, Salovaara R, Kristo P, et al: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 21:1481-1487, 1998
2. Rustgi AK: Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 331:1694-1702, 1994
3. Vasen HF, Wijnen JT, Menko FH, et al: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020-1027, 1996
4. Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000
5. Giardiello FM, Brensinger JD, Petersen GM: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 121:198-213, 2001
6. Winawer SJ, Fletcher RH, Miller L, et al: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112:594-642, 1997
7. Burke W, Petersen G, Lynch P, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer-Cancer Genetics Studies Consortium. JAMA 277:915-919, 1997
8. Syngal S, Weeks JC, Schrag D, et al: Benefits of colonoscopic surveillance and prophylactic colectomy in mutation carriers for hereditary nonpolyposis colorectal cancer. Ann Intern Med 129:787-796, 1998
9. Syngal S, Fox EA, Li C, et al: Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 282:247-253, 1999
10. Umar ABC, Terdiman JP, Syngal S, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
11. Dorval M, Gauthier G, Maunsell E, et al: No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 14:2862-2867, 2005
12. Hallowell N, Foster C, Ardern-Jones A, et al: Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 6:79-87, 2002
13. van Dijk S, Otten W, Timmermans DR, et al: What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 7:239-245, 2005
14. Domanska K, Nilbert M, Soller M, et al: Discrepancies between estimated and perceived risk of cancer among individuals with hereditary nonpolyposis colorectal cancer. Genet Test 11:183-186, 2007
15. Hadley DW, Jenkins JF, Steinberg SM, et al: Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol 26:948-954, 2008
16. Robb KA, Miles A, Wardle J: Perceived risk of colorectal cancer: Sources of risk judgments. Cancer Epidemiol Biomarkers Prev 16:694-702, 2007
17. Absetz P, Aro AR, Rehnberg G, et al: Comparative optimism in breast cancer risk perception: Effects of experience and risk factor knowledge. Psychol Health Med 5:367-376, 2000
18. Hopwood P: Breast cancer risk perception: What do we know and understand? Breast Cancer Res 2:387-391, 2000
19. Schwartz CE, Rapkin BD: Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes 2:16, 2004
20. Botkin JR, Smith KR, Croyle RT, et al: Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 118A:201-209, 2003
21. Lerman C, Hughes C, Trock BJ, et al: Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281:1618-1622, 1999
22. Scheuer L, Kauff N, Robson M, et al: Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260-1268, 2002
23. Tinley ST, Houfek J, Watson P, et al: Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A 125A:5-11, 2004
24. Stoffel EM, Ford B, Mercado RC, et al: Sharing genetic test results in Lynch syndrome: Communication with close and distant relatives. Clin Gastroenterol Hepatol 6:333-338, 2008
25. Giardiello FM, Brensinger JD, Petersen GM, et al: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336:823-827, 1997
26. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 21:2397-2406, 2003